mycin, after which the catheters were sectioned at 4-cm intervals. Only the distal 4 cm of the catheters had Background. Catheter infection is a major cause of morbidity and catheter loss in chronic haemodialysis vancomycin concentrations of 2 and 5 mg/ml, the remaining segments had levels ∏0.5 mg/ml. patients. There has been a large discrepancy in the catheter salvage rate, after an episode of documented Conclusion. Our results indicate that diffusion of vancomycin from plasma into the haemodialysis catheter is bacteraemia, whether the patients receive systemic antibiotic alone or systemic antibiotics concomitant with negligible. Thus, haemodialysis patients with central venous catheter who have to be treated for bacteraemia 'antibiotic-lock technique' (20-30% vs 100%, respectively). To test the hypothesis that vancomycin may not with systemic antibiotic therapy must always receive 'antibiotic-lock technique' of the catheter after each adequately penetrate into the lumen of the catheter, despite therapeutic plasma levels, a series of in-vivo, haemodialysis session. ex-vivo, and in-vitro experiments were performed.
received prior systemic vancomycin therapy with 14 Introduction similar patients who had additionally received 'vancomycin-lock technique' (100 mg/ml of vancomycin in Dual-lumen tunnelled, cuffed catheters are increasingly heparin solution) after each haemodialysis session.
used for permanent vascular access in patients with Results. Despite serum vancomycin concentration of limited access options for haemodialysis (HD). Infec-17 mg/ml in each group, the vancomycin concention of these catheters remains the leading cause of tration in the venous hub of the catheter was only catheter loss, and constitutes a major source of morbid-0.2±0.6 mg/ml in the former group, in sharp contrast ity and mortality in hospitalized patients. Since they to 125.6±13 mg/ml in the latter group. In the ex-vivo are used three times a week for HD, bacteraemia from experiment, four uninfected PermCaths which had any source would potentially lead to bacterial seeding been removed were immediately fixed and studied with inside the lumen of these catheters. Whether bacteraescanning electron microscopy. No cellular or fibrin mia is of catheter origin or is from other sources, e.g. barrier could be found at the terminal pore of the urinary tract infection, cellulitis, pneumonia, etc., the catheter interfering with the diffusion of vancomycin treatment of bacteraemia should also aim at sterilizafrom plasma into the catheter lumen. In the in-vitro tion of the catheter. experiments, three PermCaths filled with standard
The incidence of bacteraemia associated with chronic heparin solution were incubated for 48 h in 100 ml HD catheters is from 2 to 8 bacteraemic episodes per of plasma containing 20 mg/ml of vancomycin. 1000 catheter days [1] [2] [3] . Gram-positive organisms are Vancomycin concentration was measured in 0.3-0.5 ml responsible for most of the catheter-related infections, solution aspirated from each port of the catheters.
with normal saline which is routinely infused into the patients at previous access failures with limited sites for future the end of HD to return the blood present in the dialyser. accesses. A 2-3 week course of appropriate systemic antibiotic therapy, without catheter removal, has resulted in catheter salvage in only 20-30% of these Ex-vivo experiment patients [3, 4] . The role of antibiotic instillation into To rule out the possibility that a cellular or fibrin barrier, the catheter ('antibiotic-lock technique') to sterilize the formed at the tip of the catheter occluding the pore, might catheter intraluminally has not been well defined. In have prevented vancomycin diffusion from plasma into the the only one, uncontrolled study which evaluated the catheter lumen, four uninfected PermCaths which had been use of the 'antibiotic-lock technique' coupled with removed were immediately fixed in paraformaldehyde, and systemic antibiotic administration, 100% of the cases studied with scanning electron microscopy. The catheters had successful eradication of bacteraemia, with had been removed because the patients had acquired a defervescence within 48 h and no complications [5] . permanent vascular access. Moreover, no patient required catheter removal, i.e. 100% catheter salvage rate. However, the study was In-vitro experiments not randomized or blinded, and did not have a placebo ('heparin lock') arm.
To test the possibility that there may be some hindrance to
The discrepancy in the literature between 20-30% osmotic diffusion of vancomycin from plasma into the cathcatheter salvage rate with systemic antibiotic alone eter lumen, three PermCaths filled with the standard heparin versus 100% catheter salvage rate with systemic and solution were incubated in 100 ml of plasma containing 20 mg/ml of vancomycin. After 48 h of in-vitro incubation, 'antibiotic-lock technique' could be due to the fact that catheter, and that systemic antibiotic therapy although
To determine the extent of penetration of vancomycin achieving adequate serum antibiotic levels will not from plasma into the lumen of the catheter, two fresh result in adequate antibiotic levels within the lumen of PermCaths, filled with standard heparin solution, were incubthe catheter. To test this hypothesis we performed ated in 100 ml of plasma containing~20 mg/ml of vancoa series of in-vivo, ex-vivo, and in-vitro experiments mycin. After 48 h of in-vitro incubation, catheters were to determine the degree of penetration of systemic sectioned at 4-cm intervals, starting from the tip of the vancomycin into the lumen of the PermCath.
catheter toward the hub. The solution inside each segment was tested for vancomycin concentration.
Statistical analysis

Material and methods
The data is expressed as mean±SEM. Values were compared In order to test the hypothesis that vancomycin may not using Student's t-test. Statistical significance was considered adequately penetrate into the lumen of the catheter, despite with P<0.05. vancomycin alone, serum vancomycin concentration 48 h later was 17.0±1.3 mg/ml. However, vancomycin concentration in the aspirate from the venous hubs of In-vivo experiment the catheters was only 0.2±0.6 mg/ml. This was in sharp contrast to the 14 HD patients who had received
We studied 24 chronic HD patients who were receiving similar systemic vancomycin therapy, as well as 'vancodialysis through a PermCath, and who had received intravenous vancomycin 48 h earlier, for an infectious complication. mycin-lock technique' in whom serum vancomycin Vancomycin concentration was measured simultaneously in concentration was 17.4±1.5 mg/ml. However, vancothe plasma and in 0.3-0.5 ml solution aspirated from the mycin concentration in the aspirates from the venous venous port of the catheter, prior to HD session. The hubs of the catheters was 125.6±13 mg/ml.
vancomycin levels were compared with another 14 chronic HD patients who had received systemic vancomycin and
Ex-vivo experiment
'vancomycin-lock technique', i.e. 2 ml of heparin solution (1000 units/ml ) containing 100 mg/ml of vancomycin had The scanning electron microscopy of four uninfected been installed in each port of the catheter 48 h earlier (the PermCaths that were removed 5-7 days after the last volume capacity of each port of PermCath is 1.6-1.8 ml ). HD revealed no evidence of platelets, red blood cells of the catheter. This experiment ruled out the possibil-catheter lumen is not exposed to sufficient vancomycin concentration in the interdialytic period. Since HD ity that a fibrin or cellular barrier, formed on the tip of the catheter, was responsible for the lack of diffusion catheters are used routinely three times a week for dialysis, which would lead to bacterial seeding inside of vancomycin from plasma into the lumen of the PermCath. However, the two catheters which had clots the lumen of the catheter, lack of adequate vancomycin penetration into the lumen would result in inadequate in their lumen could have had a mechanical barrier preventing the free diffusion of vancomycin in their antibiotic coverage for the bacteria which has already seeded the catheters intraluminally. Our in-vivo, exlumen.
vivo, and in-vitro experiments suggest that the poor catheter salvage rate with systemic antibiotic therapy In-vitro experiments alone may be due to the lack of penetration of the After 48 h in-vitro incubation of three fresh PermCaths, antibiotic into the lumen of the catheter, and thus, filled with standard heparin solution, in 100 ml of persistence of bacteria intraluminally resulting in recurplasma containing vancomycin (20 mg/ml ), the rence of infection after discontinuation of the antibiotic plasma vancomycin concentration was measured therapy. Thus, in HD patients with central venous 23±2.5 mg/ml which was in sharp contrast to catheters, who have to be treated for bacteraemia, 0.2±0.1 mg/ml obtained from the venous and arterial systemic antibiotic therapy must always be associated ports of each catheter (total of six samples, each with 'antibiotic-lock technique' of the catheter (after 0.3-0.5 ml in volume). This experiment indicated that each HD session), since diffusion of the antibiotic even in the absence of any cellular/fibrin component from plasma into the catheter is negligible. Obviously, in the environment there was lack of adequate diffusion a prospective randomized double-blind placeboof vancomycin from plasma into the lumen of the controlled study is required to confirm the superiority catheter.
of systemic antibiotic with concomitant 'antibioticAfter 48 h in-vitro incubation of two fresh Perm-lock technique' over systemic antibiotic therapy alone Caths in plasma containing vancomycin (20 mg/ml ), in this patient population. only the most distal 4 cm of the catheters had vancomycin concentrations of 2 and 5 mg/ml. The remaining Acknowledgements. The authors wish to thank Ms Jennifer Stewart 4-cm segments had vancomycin concentrations and Ms Tracy Line for their secretarial assistance. ∏0.5 mg/ml. This suggested that vancomycin had only penetrated the most distal 4 cm of the catheter, despite 48 h of incubation in plasma containing adequate References vancomycin concentration.
